In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibiotics

Clinical Microbiology and Infection

Volumn 5, Issue 1, 1999, Pages 32-36

  MacGowan, Alasdair P ^a,b   Rynn, Caroline ^a   Wootton, Mandy ^a   Bowker, Karen E ^a   Holt, H Alan ^a   Reeves, David S ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b NORTH BRISTOL NHS TRUST   (United Kingdom)

Author keywords

Antimicrobial interaction; Colistin; Pseudomonas aeruginosa; Time kill curves

Indexed keywords

ANTIINFECTIVE AGENT; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; MEROPENEM; PIPERACILLIN;

ARTICLE; BACTERICIDAL ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STATISTICAL ANALYSIS;

EID: 0032901657     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00095.x     Document Type: Article

References (13)

1. Kucers A, Bennett NM, eds. Polymyxins in the use of antibiotics, a comprehensive review with clinical emphasis. London: William Heinemann Medical Books, 1987: 899.
2. Catchpole CR, Andrews JM, Brenwald N, Wise R. A reassessment of the in vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother. 1996; 39: 255-60.
3. Jensen T, Pederson SS, Garne S, Heilmann C, Hoiby NP, Koch C. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother 1987; 19: 831-8.
4. Conway SP, Pond MN, Watson A, Robey HL, Goldman M. A safety profile of intravenous colistin (colomycin) in adult CF care [Abstract P3]. In: Proceeding of the 20th European Cystic Fibrosis Conference, 1995 Brussels, Belgium.
5. Chan EL, Zabransky RJ. Determination of synergy by two methods with eight antimicrobial combinations against tobramycin susceptible and tobramycin resistant strains of Pseudomonas. Diagn Microbiol Infect Dis 1987; 6: 157-64.
6. Richards RM, Xing DK. Investigation of the synergism between combinations of ciprofloxacin, polymyxin, sulphadiazine and p-aminosalicylic acid. J Pharm Pharmacol 1993; 45: 171-5.
7. Gould IM, Milne K. In vitro pharmacodynamic studies with piperacillin/tazobactam with gentamicin and ciprofloxacin. J Antimicrob Chemother 1997; 39: 53-61.
8. Wootton M, Hedges AJ, Bowker KE, Holt HA, Reeves DS, MacGowan AP. A critical assessment of the agar dilution chequerboard technique for studying in vitro antimicrobial interactions using a representative β lactam, aminoglycoside and fiuoroquinolone. J Antimicrob Chemother 1995; 35: 569-76.
9. Rand KH, Houck HJ, Brown P, Bennett D. Reproducibility of the microdilution chequerboard method for antibiotic synergy. Antimicrob Agents Chemother 1993; 37: 612-15.
10. MacGowan AP, Wootton M, Hedges AJ, Bowker KE, Holt HA, Reeves DS. A new time kill method of assessing the relative efficacy of antimicrobial agents alone and in combination using a representative β lactam, aminoglycoside and fluoroquinolone. J Antimicrob Chemother 1996; 28: 193-203.
11. Krogstad DJ, Moellering RC. Antimicrobial combination. In Lorian V, ed. Antibiotics in laboratory medicine, 3rd edn. Baltimore: William & Wilkins, 1986: 537-95.
12. Lorian V. The mode of action of antibiotics on Gram negative bacilli. Arch Intern Med 1971; 128: 623-32.
13. Hu FR, Luh KT. Pseudomonas aeruginosa. Isolated from corneal ulcer: susceptibility to antimicrobial agents tested alone or in combination. J Formosan Med Assoc 1992; 92: 190-4.